2m 2m 2m 2m 2m 2m 2m
SOLIGENIX (SNGX)
NASDAQ
$0.51-$0.24 (-32.56%)
Price as of Jun 03, 2026 6:57 PM EDT- $13.5MMarket Cap
- -61.60%1-Year Change
- BiotechnologyIndustry
SOLIGENIX (SNGX)
$0.51-$0.24 (-32.56%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 119,371 0.00% | 119,371 -85.78% | 839,359 -11.55% | 948,911 +15.12% | |
Cost of Revenue | 119,371 0.00% | 119,371 -83.91% | 742,048 +34.72% | 550,822 -24.40% | |
Gross Profit | 0 -100.00% | 97,311 0.00% | 97,311 -75.56% | 398,089 +316.29% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -7.5M +43.31% | -5.2M +57.68% | -3.3M -58.30% | -7.9M -5.31% | |
Depreciation and Amortization Expense | 3,224 -44.55% | 5,814 -11.29% | 6,554 -73.32% | 24,562 -28.10% | |
Total Operating Expenses | 11.8M +25.49% | 9.4M +21.09% | 7.8M -46.74% | 14.6M +10.58% | |
Operating Profit | -11.8M +25.49% | -9.4M +22.62% | -7.7M -45.94% | -14.2M +8.36% | |
Interest Income | 125 +190.70% | 43 N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | -192,998 +292.84% | -49,129 -94.03% | -822,611 -4.63% | |
Interest Income and Expense and Net | 125 +100.06% | -192,955 +292.75% | -49,129 -94.03% | -822,611 -4.63% | |
Total Nonoperating Income and Expense | 258,481 -66.16% | 763,807 +462.69% | -210,593 -70.52% | -714,370 +159.93% | |
Income before Taxes | -11.6M +33.56% | -8.7M +9.70% | -7.9M -47.11% | -15.0M +11.46% | |
Income Taxes | -506,615 +23.83% | -409,114 -76.86% | -1.8M +53.07% | -1.2M +33.56% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -11.1M +34.04% | -8.3M +34.62% | -6.1M -55.50% | -13.8M +9.94% | |
Net Income from Continuing Operations Applicable to Common | -11.1M +34.04% | -8.3M +34.62% | -6.1M -55.50% | -13.8M +9.94% | |
Basic EPS and Net Income | -2.14 -57.03% | -4.98 +530.38% | -0.79 -83.58% | -4.81 +1,451.61% | |
Diluted EPS and Net Income | -2.14 -57.03% | -4.98 +530.38% | -0.79 -83.58% | -4.81 +1,451.61% | |
Basic Weighted Average Shares | 5.2M +212.50% | 1.7M -78.60% | 7.8M +170.19% | 2.9M -92.85% | |
Diluted Weighted Average Shares | 5.2M +212.50% | 1.7M -78.60% | 7.8M +170.19% | 2.9M -92.85% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 7.9M +1.49% | 7.8M -7.42% | 8.4M -36.78% | 13.4M -48.70% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 7.9M +1.49% | 7.8M -7.42% | 8.4M -36.78% | 13.4M -48.70% | |
Total Current Assets | 8.8M +0.23% | 8.8M -7.14% | 9.5M -31.37% | 13.9M -47.86% | |
Accumulated Depreciation | N/A N/A | N/A N/A | 121,320 +5.71% | 114,766 -31.63% | |
Property and Plant and Equipment and Net | 8,772 +43.50% | 6,113 -48.75% | 11,927 -35.46% | 18,481 -16.83% | |
Total Long-Term Assets | 8,772 +43.50% | 6,113 -80.98% | 32,133 +314.62% | 7,750 0.00% | |
Total Assets | 9.2M +3.00% | 9.0M -8.48% | 9.8M -31.39% | 14.3M -46.86% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.4M 0.00% | 1.4M -38.98% | 2.3M -77.27% | 9.9M +2,945.64% | |
Total Current Liabilities | 3.7M -23.70% | 4.8M -21.19% | 6.2M -62.75% | 16.5M +162.54% | |
Total Long-Term Debt | 13.0M N/A | 0 -100.00% | 1.0M N/A | 0 -100.00% | |
Total Long-Term Liabilities | 244,121 +118.23% | 111,862 -90.04% | 1.1M +380.59% | 233,627 +120.09% | |
Total Liabilities | 3.9M -18.67% | 4.8M -33.35% | 7.3M -56.57% | 16.8M +3.74% | |
Retained Earnings | -245.1M +4.74% | -234.0M +3.66% | -225.7M +2.80% | -219.6M +6.71% | |
Total Stockholders Equity | 5.3M +28.51% | 4.1M +63.26% | 2.5M +202.09% | -2.5M -123.04% | |
Total Shares Outstanding | 10.1M +301.12% | 2.5M -75.77% | 10.4M +256.81% | 2.9M -93.22% | |
Cash Flow | |||||
Cash from Operating Activities | -10.3M +22.17% | -8.4M -2.33% | -8.6M -31.98% | -12.6M +7.75% | |
Capital Expenditures | 5,883 N/A | N/A N/A | 13,073 0.00% | 13,073 +10.89% | |
Cash from Investing Activities | -5,883 N/A | N/A N/A | -13,073 0.00% | -13,073 +10.89% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 10.4M +33.84% | 7.8M +111.88% | 3.7M +4,668.89% | 76,821 -99.60% | |
Financials Ratio | |||||
Gross Margin | 0.00% N/A | 0.00% -100.00% | 11.59% -72.36% | 41.95% +261.61% | |
Operating Margin | -9,923.24% +25.49% | -7,907.70% +762.23% | -917.12% -38.88% | -1,500.55% -5.88% | |
Return on Assets | -121.75% +38.18% | -88.11% +72.74% | -51.01% -23.94% | -67.06% +24.93% | |
Return on Equity | -235.50% -5.41% | -248.97% -98.95% | -23,803.12% +7,017.45% | -334.43% +92.71% | |
Revenue Growth | 0.00% +100.00% | -85.78% +642.99% | -11.54% -176.35% | 15.12% +123.24% | |
Current Ratio | 2.39 +31.37% | 1.82 +17.83% | 1.55 +84.26% | 0.84 -80.14% | |
Cash Ratio | 2.15 +33.02% | 1.61 +17.47% | 1.37 +69.75% | 0.81 -80.46% | |
Debt-to-Equity Ratio | 2.72 +714.61% | 0.33 -74.21% | 1.29 +132.27% | -4.01 -521.89% | |
Debt-to-Assets Ratio | 1.56 +916.53% | 0.15 -54.00% | 0.33 -51.98% | 0.69 +82.92% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow